ProQR Therapeutics N.V. (PRQR:NASDAQ) rocketted at $9.22, representing a gain of 62.3%. On Wed 24 Mar 21, PRQR:NASDAQ hit a New 2-Week Intraday High of $6.13. The stock got featured on our News Catalysts scanner on Wed 24 Mar 21 at 07:21 AM in the 'BIOTECH' category. From Wed 10 Mar 21, the stock recorded 70.00% Up Days and 36.36% Green Days
The stock spiked on Tue 26 Jan 21 at $6.34 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About ProQR Therapeutics N.V. (PRQR:NASDAQ)
ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for the treatment of severe genetic disorders.
Top 10 Gainers:
- GCAC (GCAC:NASDAQ), 100%
- ProQR Therapeutics N.V. (PRQR:NASDAQ), 62.32%
- Koss Corporation (KOSS:NASDAQ), 57.13%
- GameStop Corp. (GME:NYSE), 52.69%
- Immutep Limited (IMMP:NASDAQ), 39.92%
- Houston Wire & Cable Company (HWCC:NASDAQ), 37.63%
- Cellect Biotechnology Ltd. (APOP:NASDAQ), 36.68%
- KBS Fashion Group Limited (KBSF:NASDAQ), 31.3%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 26.77%
- FreightCar America, Inc. (RAIL:NASDAQ), 23.39%